CEL-SCI Says Publication Supports Strategy to Seek Early Approval for Multikine

TipRanksApr 8 09:55 ET

Express News | CEL-SCI Announces Publication From Prior 3 Study Of Multikine In Journal 'Pathology and Oncology Research'

BenzingaMar 24 09:07 ET

CEL-SCI Reports New Data: Treatment With Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

BusinesswireMar 24 09:00 ET

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

BenzingaMar 18 06:04 ET

CEL-SCI Announces Pricing of $2.5 Million Offering

BusinesswireMar 17 15:24 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaMar 17 08:11 ET